The Neutrogena sunscreen class action lawsuit involves a serious contamination issue—but not PFAS as the title suggests. The actual problem is benzene, a known carcinogen discovered through third-party testing by Valisure in spray and lotion sunscreens. Neutrogena products were particularly affected, accounting for 10 of the 14 highest-concentration benzene batches tested, leading Johnson & Johnson to recall affected products in July 2021. The settlement offers $1.75 million in vouchers to affected consumers, with each product eligible for $10.58 in credit and a maximum household payout of $21.16 for up to two claimed products purchased between May 26, 2015, and April 8, 2022.
However, the settlement process has hit a major snag. In July 2024, the 11th Circuit Court of Appeals vacated final approval, ordering a recalculation of both voucher amounts and attorneys’ fees. This means vouchers have not yet been issued to consumers, and the case remains in flux. This article explains what contaminated products affected consumers, how the settlement currently works, what the appeal means for claimants, and how to track your claim.
Table of Contents
- What Contamination Does Neutrogena’s Sunscreen Actually Contain?
- How Johnson & Johnson Responded and Why the Recall Mattered
- Understanding the Settlement Structure and Voucher Values
- What Changed in the July 2024 Appeals Court Decision?
- Eligibility and What Documentation You’ll Need
- Tracking Your Claim and Staying Updated
- What This Case Means for Sunscreen Safety Going Forward
What Contamination Does Neutrogena’s Sunscreen Actually Contain?
The contamination is benzene, not PFAS or any other chemical. Benzene is a volatile organic compound classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC), meaning there is sufficient evidence it causes cancer in humans. The U.S. Environmental Protection Agency (EPA) has also classified benzene as a known human carcinogen.
Unlike PFAS, which are “forever chemicals” that break down very slowly in the environment and in human tissue, benzene evaporates readily from products and is primarily a concern when inhaled or absorbed during application. The contamination was discovered by Valisure, a private testing laboratory, which published findings showing benzene in various sunscreen products from multiple manufacturers. Neutrogena was hit particularly hard—the testing revealed that 10 of the 14 batches with the highest benzene concentrations were Neutrogena products. This wasn’t a case of Neutrogena deliberately adding benzene; rather, it appears to be a manufacturing or quality-control failure where a solvent used in production wasn’t properly removed. Importantly, this contamination wasn’t limited to Neutrogena’s sunscreens alone—other brands were also affected—but Neutrogena’s concentration of high-level contamination made it the primary focus of this lawsuit.
How Johnson & Johnson Responded and Why the Recall Mattered
After the Valisure findings became public, Johnson & Johnson did not wait for regulatory action. In July 2021, the company voluntarily recalled affected Neutrogena and Aveeno sunscreen products sold in spray and lotion formats. The recall covered products manufactured during the period when contamination could have occurred. Johnson & Johnson notified healthcare providers and retailers and provided refund information to consumers who had already purchased affected products.
However, a critical limitation applies here: the recall only covered products purchased up to July 2021. The settlement lawsuit covers purchases from May 26, 2015, through April 8, 2022—a period that extends beyond the official recall date. This means some consumers who purchased products after July 2021 but before April 2022 may have received contaminated sunscreen without Johnson & Johnson’s knowledge at the time, and these purchases are still eligible for settlement vouchers. The company’s decision to recall voluntarily rather than waiting for FDA action was significant—it showed acknowledgment of the problem, but it also raised questions about why the contamination wasn’t caught during the manufacturing process itself.
Understanding the Settlement Structure and Voucher Values
The settlement agreement totaled $1.75 million in consumer vouchers, not a cash payout. This is an important distinction because it means affected consumers receive credit toward future Neutrogena, Aveeno, or other Johnson & Johnson skincare products rather than receiving money directly into their bank accounts. Each affected product eligible for a claim receives $10.58 in voucher credit. If a consumer can document purchasing two affected products during the eligible period, the maximum household payout is $21.16 in total vouchers.
For example, if you purchased a Neutrogena Ultra Sheer Dry-Touch SPF 50 sunscreen spray in August 2018 and a Neutrogena Clear Face Lotion SPF 30 in March 2020, both within the coverage window, you could claim $21.16 in vouchers—the maximum allowed. However, if you purchased five Neutrogena sunscreens during the period, the settlement caps your total voucher value at $21.16, not $52.90. This cap represents a significant limitation for consumers who stockpile sunscreen or used multiple affected products. The vouchers are typically issued through a third-party claims administrator and can usually be applied to purchases on online retailers or in physical stores that accept them.
What Changed in the July 2024 Appeals Court Decision?
On July 19, 2024, the U.S. Court of Appeals for the 11th Circuit vacated the final approval of the settlement, meaning it sent the case back to the lower court for modifications. The appeals court didn’t reject the settlement outright; instead, it found problems with how voucher amounts and attorneys’ fees were calculated. Specifically, the court questioned whether the voucher values adequately compensated consumers for the risk they faced from benzene exposure and whether the attorneys’ fees were proportional to the settlement’s actual value.
This decision fundamentally changed the settlement’s status. Rather than being fully approved and moving to voucher distribution, the case is now in a recalculation phase. No vouchers have been issued to date because of this hold. Consumers who filed claims during the initial claims window face uncertainty about when they’ll receive their vouchers and whether the final voucher amounts will differ from the initially promised $10.58 per product. The appeals court’s intervention is typical in high-profile consumer class actions and often results in either higher voucher amounts or adjustments to how attorneys’ fees are deducted.
Eligibility and What Documentation You’ll Need
To qualify for a settlement voucher, you must have purchased an affected Neutrogena or Aveeno sunscreen product in spray or lotion format between May 26, 2015, and April 8, 2022. You’ll need proof of purchase—typically a receipt from a retailer, pharmacy, or online store. If you no longer have your original receipt, the claims administrator may accept credit card statements, bank records showing the purchase, or even photographs of the product’s packaging if you still have the bottle. A critical limitation: if you threw away the product and have no documentation whatsoever, you likely cannot claim a voucher.
The settlement requires objective evidence of purchase. Additionally, if you purchased the product after July 2021 (when the recall began), you’ll need to show that the product batch number matches one identified as containing benzene. The claims administrator has a database of affected batch numbers, and you can match your product to it. If you purchased before July 2021, the burden is less strict because the recall itself creates a presumption that products from that period in certain product lines were affected.
Tracking Your Claim and Staying Updated
The official settlement website is sunproductsettlement.com, where you can submit a claim, check the status of an existing claim, and receive updates about the case’s progress. Given the July 2024 appeals court decision, it’s especially important to visit this site regularly to learn when vouchers will actually be distributed. The site also maintains a list of affected product batch numbers and links to updated information about the appeals court decision.
You should not rely on third-party claim sites or advertisements you see on social media, as scammers sometimes create fake claims portals or charge fees to help with claims. The official settlement site charges nothing to file a claim—it’s free for consumers. If you’ve already filed a claim and received a claim number, keep that number safe and use it to check your claim status periodically.
What This Case Means for Sunscreen Safety Going Forward
The Neutrogena benzene contamination and subsequent lawsuit highlight a gap in over-the-counter sunscreen regulation. While the FDA approves sunscreen formulations, the manufacturing process itself—including the removal of industrial solvents—is less rigorously overseen than some would expect. The Valisure testing that uncovered the problem was conducted by a private laboratory, not a government agency, which raises questions about why routine testing wasn’t catching contamination before products reached consumers.
This case may influence how Johnson & Johnson and other sunscreen manufacturers approach quality control, particularly for spray formulations where benzene is most likely to concentrate. It also underscores the value of independent testing labs and consumer advocacy. For consumers, the key takeaway is that sunscreen remains critical for skin cancer prevention—the benefits of sun protection far outweigh the risk from occasional benzene exposure—but choosing products from manufacturers with strong quality control and staying informed about recalls is prudent.